Enrollment in a fracture liaison service does not guarantee post fracture follow-up.

Objective: To assess post fracture outpatient follow-up adherence in a cohort of patients enrolled in a fracture liaison service (FLS).

Methods: We analyzed FLS registry data for patients who were hospitalized with fragility fractures from June 2020 through December 2022 and determined the proportion of patients who kept their follow-up appointments in outpatient endocrinology and orthopedic clinics.

Results: We identified 295 patients who were eligible for the FLS pathway; from this group, 57 declined an endocrinology follow-up visit.

Assessment of gait and posture characteristics using a smartphone wearable system for persons with osteoporosis with and without falls.

We used smartphone technology to differentiate the gait characteristics of older adults with osteoporosis with falls from those without falls. We assessed gait mannerism and obtained activities of daily living (ADLs) with wearable sensor systems (smartphones and inertial measurement units [IMUs]) to identify fall-risk characteristics. We recruited 49 persons with osteoporosis: 14 who had a fall within a year before recruitment and 35 without falls.

Quantifying misdiagnosis rates from cross-calibration biases and precision errors in dual-energy X-ray absorptiometry of the femoral neck.

Background: Dual-energy X-ray absorptiometry (DXA) is an exam that measures areal bone mineral density (aBMD) and is regularly used to diagnose and monitor osteoporosis. Except for exam quality issues such as operator error, the quantitative results of an exam are not modified by a radiologist or other physician. DXA cross-calibration errors can shift diagnoses, conceivably leading to alternate intervention decisions and patient outcomes.

Subsequent Fracture Prevention in Patients 50 Years and Older With Fragility Fractures: A Quality Improvement Initiative.

Because of osteoporosis, patients older than 50 years with fragility fractures are at risk of further fractures. We developed a quality improvement initiative based on an evidence-based Fracture Liaison Service (FLS) model of care to help prevent subsequent fractures. Previous to the implemented FLS model, less than 13% of patients with fragility fractures were assessed for osteoporosis at our institution.

Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.

Unlabelled: Vitamin D deficiency is common among patients with end-stage liver disease (ESLD). The primary aim of our study was to assess the prevalence of vitamin D deficiency, secondary hyperparathyroidism, and bone disease in patients with ESLD awaiting LT.

Methods: We retrospectively studied 190 patients at our center.

Clinical and bone density outcomes of tumor-induced osteomalacia after treatment.

Objective: To report the outcomes of tumor-induced osteomalacia after treatment, particularly related to recovery of bone mass.

Methods: We review the clinical course of a 61-year-old man extremely debilitated from multiple fractures and neuromuscular weakness due to tumor-induced osteomalacia and report the changes in biochemical markers and bone density after removal of the causative neoplasm.

Results: At the time of diagnosis, the patient's serum phosphorus and 1,25 dihydroxyvitamin D levels were depressed, and his fibroblast growth factor-23 level was markedly elevated.

Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum.

Background: Little is known about management of hyperglycemia in inpatients.

Objective: To gain insight into caring for hospitalized patients with hyperglycemia.

Design: Retrospective analysis.

Diabetes care in the hospital: is there clinical inertia?

Background: Effective control of hospital glucose improves outcomes, but little is known about hospital management of diabetes.

Objective: Assess hospital-based diabetes care delivery.

Design: Retrospective chart review.

Thymic hyperplasia presenting as anterior mediastinal mass in 2 patients with Graves disease.

Graves disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. The autoantibodies mimic the effect of the hormone on thyroid cells, which stimulates autonomous production of thyroxine and triiodothyronine. It has been hypothesized that cross-reactivity of autoantibodies may result in Graves ophthalmopathy and dermopathy.